Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Atherosclerosis Research

Background:

• Coronary bifurcations are prone to turbulent flow, atherothrombosis, and plaque rupture.
• Percutaneous coronary intervention (PCI) for bifurcation lesions increases thrombotic event risk.
• Current management strategies lack consensus, especially regarding PCI approach and antithrombotic therapy.

Purpose of the Study:

• To address the lack of consensus in managing coronary bifurcation lesions.
• To propose a uniform therapeutic approach for bifurcation PCI.
• To develop an algorithm for optimal patient management based on clinical factors.

Main Methods:

• Analysis of existing evidence from dedicated studies and large trial substudies.
• Involvement of international opinion leaders from the European Bifurcation Club (EBC).
• Development of a management algorithm considering clinical presentation, bleeding risk, and procedural strategy.

Main Results:

• Evidence synthesis from various sources, including expert opinions.
• Identification of key factors influencing risk in bifurcation PCI.
• Proposal of a structured algorithm for clinical decision-making.

Conclusions:

• A unified approach to coronary bifurcation PCI is clinically needed.
• The proposed algorithm aims to optimize treatment strategies.
• Management should integrate patient presentation, bleeding risk, and procedural considerations.